Diabetes insipidus in Langerhans cell histiocytosis: When is treatment indicated?
Abla
Oussama
O
Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. oussama.abla@sickkids.ca
Weitzman
Sheila
S
Minkov
Milen
M
McClain
Kenneth L
KL
Visser
Johannes
J
Filipovich
Alexandra
A
Grois
Nicole
N
D003919:Diabetes Insipidus / Q000150:complications* / Q000628:therapy*; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications* / Q000628:therapy*; D006801:Humans